BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6531385)

  • 1. [Antiserotonergic effect of antidepressives in quipazine-induced headshake behavior in the rat].
    Fischer W; Müller M
    Pharmazie; 1984 Nov; 39(11):776-7. PubMed ID: 6531385
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic effect of antidepressives in L-5-HTP-induced headshake behavior in the rat].
    Fischer W
    Pharmazie; 1984 Nov; 39(11):777-8. PubMed ID: 6335755
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antiserotonergic effect of antidepressives in L-5-HTP-induced head shaking behavior in the rat].
    Fischer W; Müller M
    Pharmazie; 1984 Apr; 39(4):277-8. PubMed ID: 6610882
    [No Abstract]   [Full Text] [Related]  

  • 4. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
    Langlais PJ; Gabay S
    J Neurosci Res; 1977; 3(2):135-41. PubMed ID: 563925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the behavioral effects of para-chloroamphetamine, chlordimeform, quipazine, and intraventricular serotonin in the rat.
    Pfister WR; Noland V; Lowy MT; Nichols DE; Yim GK
    Commun Psychopharmacol; 1978; 2(4):287-95. PubMed ID: 729354
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats.
    Lipham LB; Booth NH; Jernigan AD; Robbins JD; Hatch RC
    Am J Vet Res; 1986 May; 47(5):1089-91. PubMed ID: 3717731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Excellence of quipazine in the characterization of serotoninergic receptors and mechanisms].
    Hong E
    Gac Med Mex; 1982 Apr; 118(4):158-64. PubMed ID: 7117731
    [No Abstract]   [Full Text] [Related]  

  • 8. Is there a "serotonergic syndrome" in neonatal rat pups?
    Ristine LA; Spear LP
    Pharmacol Biochem Behav; 1985 Feb; 22(2):265-9. PubMed ID: 2858868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.
    Friedman RL; Barrett RJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1984 Mar; 228(3):628-35. PubMed ID: 6707913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin type 2 antagonists inhibit lordosis behavior in the female rat: reversal with quipazine.
    Mendelson SD; Gorzalka BB
    Life Sci; 1986 Jan; 38(1):33-9. PubMed ID: 2934598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of opioids on central serotonin transmission and despair test.
    Tamborska E; Malec D; Modzelewski J; Langwiński R
    Acta Med Pol; 1982; 23(1-2):49-62. PubMed ID: 7187600
    [No Abstract]   [Full Text] [Related]  

  • 12. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ; Commissaris RL; Warner MR; Rech RH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serotonin antagonistic effect of antidepressives on the isolated stomach strip of the rat].
    Fischer W; Schubert S; Müller M
    Pharmazie; 1984 Dec; 39(12):859-61. PubMed ID: 6531398
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative anorexigenic activity and other pharmacological properties of quipazine and its N-acyl derivatives].
    Trubitsyna TK; Asnina VV; Mashkovskiĭ MD
    Farmakol Toksikol; 1986; 49(1):44-9. PubMed ID: 3948987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of a model for central serotonin receptor activation.
    Matthews WD; Smith CD
    Life Sci; 1980 Apr; 26(17):1397-403. PubMed ID: 6247593
    [No Abstract]   [Full Text] [Related]  

  • 16. Quipazine-induced behavior in neonatal rat pups.
    Spear LP; Ristine LA
    Pharmacol Biochem Behav; 1981 Jun; 14(6):831-4. PubMed ID: 7255519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pyrazidol on the central serotonergic system.
    Sypniewska M; Przegaliński E
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):313-9. PubMed ID: 7322945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
    Rokosz-Pelc A; Antkiewicz-Michaluk L; Vetulani J
    J Pharm Pharmacol; 1980 Mar; 32(3):220-2. PubMed ID: 6103943
    [No Abstract]   [Full Text] [Related]  

  • 19. Quipazine-induced stimulus control in the rat.
    Winter JC
    Psychopharmacology (Berl); 1979 Feb; 60(3):265-9. PubMed ID: 108704
    [No Abstract]   [Full Text] [Related]  

  • 20. Quipazine, a new type of antidepressant agent.
    Rodríguez R; Pardo EG
    Psychopharmacologia; 1971; 21(1):89-100. PubMed ID: 5567294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.